Related Experiment Video
Updated: May 26, 2025
MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
Published on: February 7, 2025
MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
Megan E Honeywell1, Michael J Lee2
1Department of Systems Biology, UMass Chan Medical School.
Abstract:
Systematic screening of gain- or loss-of-function genetic perturbations can be used to characterize the genetic dependencies and mechanisms of regulation for essentially any cellular process of interest. These experiments typically involve profiling from a pool of single gene perturbations and how each genetic perturbation affects the relative cell fitness. When applied in the context of drug efficacy studies, often called chemo-genetic profiling, these methods should be effective at identifying drug mechanisms of action. Unfortunately, fitness-based chemo-genetic profiling studies are ineffective at identifying all components of a drug response. For instance, these studies generally fail to identify which genes regulate drug-induced cell death. Several issues contribute to obscuring death regulation in fitness-based screens, including the confounding effects of proliferation rate variation, variation in the drug-induced coordination between growth and death, and, in some cases, the inability to separate DNA from live and dead cells. MEDUSA is an analytical method for identifying death-regulatory genes in conventional chemo-genetic profiling data. It works by using computational simulations to estimate the growth and death rates that created an observed fitness profile rather than scoring fitness itself. Effective use of the method depends on optimal tittering of experimental conditions, including the drug dose, starting population size, and length of the assay. This manuscript will describe how to set up a chemo-genetic profiling study for MEDUSA-based analysis, and we will demonstrate how to use the method to quantify death rates in chemo-genetic profiling data.
Insights
This study introduces MEDUSA, a computational method to identify genes regulating cell death in drug response studies. MEDUSA analyzes genetic perturbation data to estimate growth and death rates, improving drug mechanism discovery.
Area of Science:
- Genetics
- Computational Biology
- Pharmacology
Background:
- Systematic genetic screening, including chemo-genetic profiling, identifies gene functions and drug mechanisms by measuring cell fitness.
- Traditional fitness-based screens struggle to identify genes regulating drug-induced cell death due to confounding factors like proliferation rates and cell death separation.
- This limitation hinders a complete understanding of drug responses and mechanisms of action.
Purpose of the Study:
- To introduce MEDUSA, an analytical method designed to identify death-regulatory genes from conventional chemo-genetic profiling data.
- To address the limitations of fitness-based screens in detecting genes involved in drug-induced cell death.
- To provide a framework for setting up chemo-genetic profiling experiments optimized for MEDUSA analysis.
Main Methods:
- MEDUSA utilizes computational simulations to estimate cellular growth and death rates from observed fitness profiles.
- The method bypasses direct fitness scoring, focusing instead on inferring underlying kinetic parameters.
- Experimental conditions, including drug dose, initial population size, and assay duration, require careful optimization for effective MEDUSA application.
Main Results:
- MEDUSA enables the quantification of death rates within chemo-genetic profiling datasets.
- The method provides a computational approach to overcome the challenges of identifying death-regulatory genes in drug efficacy studies.
- Demonstrates the application of MEDUSA for analyzing complex drug response data.
Conclusions:
- MEDUSA offers a novel computational solution for identifying genes that regulate cell death in response to drug treatments.
- By estimating growth and death rates, MEDUSA enhances the characterization of drug mechanisms beyond traditional fitness-based approaches.
- This method is crucial for a comprehensive understanding of drug efficacy and cellular responses to pharmacological interventions.
